Pipeline meetings

Horizon Scanning regularly organises pipeline meetings with businesses in the pharmaceuticals industry. At these meetings, we talk about what drugs will be marketed in Denmark over the next two to three years. The dialogue at pipeline meetings contributes valuable insight and knowledge for both us and our suppliers.

Photographer: Anne-Li Engström

Pipeline meetings with pharmaceutical companies are an important source of information, when Horizon Scanning forecasts the future drugs on the Danish market.
Companies talk about what products they expect to launch in the years to come. This applies in relation to the new drugs and new indications of existing pharmaceuticals, as well as new pharmaceutical forms.
At a pipeline meeting, we ask the company to supply specific and structured information about the relevant pharmaceuticals.
This could be:
  • Pharmaceutical substance and trade (brand) name
  • Planned indication
  • Medicinal value compared with existing treatment
  • Timetable for filing, authorisation and launch
  • Population of patients who may be relevant users of the pharmaceutical in Denmark
  • Budget impact and any changes in structure and treatment process
  • Information about future patent expiries
  • Expected price
Amgros takes part in pipeline meetings with representatives from Horizon Scanning, health economics, tendering procedures and negotiations. This means that the pharmaceuticals company has an opportunity to meet our specialists and receive replies to questions about the Danish pharmaceuticals system.
Data generated at pipeline meetings is always treated properly and carefully. We never publish material containing commercially sensitive information. Amgros is subject to the Access to Public Administration Files Act, and this means that we work with a high degree of confidentiality in our data processing. We are always willing to enter into specific non-disclosure agreements with companies.

If you would like to book a pipeline meeting, you are most welcome to contact us. We would like to know who from your company will be taking part and what therapeutic areas the meeting is about. Amgros will then be able to delegate the right specialists for the meeting, so that all parties receive the best possible outcome from the dialogue.

Read more

Pipeline meetings

Find your way through EMA

We monitor and register applications from pharmaceutical companies to the European Medicines Agency (EMA).

Pipeline meetings

Horizon Scanning

Amgros works systematically to establish an overview of the future opportunities for pharmaceuticals treatments

Pipeline meetings

Latest news

If you would like to receive news from Amgros directly in your inbox, sign up for our newsletter. You can choose between general news or the latest news from Horizon Scanning.

Pipeline meetings

Pharmaceuticals in the pipeline in the EMA

We monitor and register applications from pharmaceutical companies to the European Medicines Agency (EMA): Both applications for marketing authorisations for new pharmaceuticals, as well as applications for changes to existing marketing authorisations such as extensions of indications and other extensions.


Birgit Rasmussen


I work with tendering procedures in a broad sense. For example, I’m responsible for coordinating supplier meetings at Amgros in connection with discussions about pharmaceuticals at the Danish Medicines Council.